Clinical Trial Update: Detecting Early Onset Pre-eclampsia and Use of Placental Growth Factor (PlGF) for Marker of Trisomy 21

View source ↗

Summary

A terminated clinical trial evaluating placental growth factor as a marker for early onset preeclampsia and trisomy 21 detection in pregnancy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Down Syndrome
• Preeclampsia

Snippet

Sponsor: Clinique Ovo | Conditions: Pregnancy | Status: TERMINATED